Literature DB >> 21029302

Glucose regulation of β-cell stress in type 2 diabetes.

G Leibowitz1, E Bachar, M Shaked, A Sinai, M Ketzinel-Gilad, E Cerasi, N Kaiser.   

Abstract

In type 2 diabetes, the β-cell is exposed to chronic hyperglycaemia, which increases its metabolic activity, with excess generation of reactive oxygen species (ROS) as a consequence. ROS accumulation induces both oxidative and endoplasmic reticulum (ER) stress, which may lead to β-cell dysfunction and apoptosis. Recent data suggest that oxidative and ER stress are interconnected, although the mechanisms involved in nutrient regulation of the different stress pathways are dissimilar. Several components of the oxidative and ER stress machineries have important roles in the physiological response to glucose and are thus necessary for normal β-cell function. Glucose stimulates signalling pathways that provide crucial messages for β-cell adaptation to metabolic stress; however, the same pathways may eventually lead to apoptosis. Dynamic, temporally fluctuating activation of stress signalling is probably required for the maintenance of β-cell survival, whereas its persistent activation results in β-cell dysfunction and apoptosis. Thus, stress signalling is a 'double-edged sword' that may promote adaptation or apoptosis according to the balance between the divergent outputs of the various pathways. Developing new strategies for β-cell protection based on inhibition of oxidative and/or ER stress requires comprehensive understanding of the switch from β-cell adaptation to β-cell apoptosis under conditions of metabolic stress, such as occurs under hyperglycaemic conditions.
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21029302     DOI: 10.1111/j.1463-1326.2010.01280.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  18 in total

Review 1.  SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects.

Authors:  Ele Ferrannini; Anna Solini
Journal:  Nat Rev Endocrinol       Date:  2012-02-07       Impact factor: 43.330

2.  d-Retro Inverso Amylin and the Stability of Amylin Fibrils.

Authors:  Preeti Pandey; Natalie Nguyen; Ulrich H E Hansmann
Journal:  J Chem Theory Comput       Date:  2020-07-28       Impact factor: 6.006

Review 3.  Targeting pancreatic β cells for diabetes treatment.

Authors:  Chirag Jain; Sara Bilekova; Heiko Lickert
Journal:  Nat Metab       Date:  2022-09-21

Review 4.  Hyperglycemic Stress and Carbon Stress in Diabetic Glucotoxicity.

Authors:  Xiaoting Luo; Jinzi Wu; Siqun Jing; Liang-Jun Yan
Journal:  Aging Dis       Date:  2016-01-02       Impact factor: 6.745

5.  Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model.

Authors:  B A Omar; J Vikman; M S Winzell; U Voss; E Ekblad; J E Foley; B Ahrén
Journal:  Diabetologia       Date:  2013-05-02       Impact factor: 10.122

Review 6.  Endoplasmic reticulum stress in the β-cell pathogenesis of type 2 diabetes.

Authors:  Sung Hoon Back; Sang-Wook Kang; Jaeseok Han; Hun-Taeg Chung
Journal:  Exp Diabetes Res       Date:  2011-09-08

Review 7.  Darier Disease - A Multi-organ Condition?

Authors:  Etty Bachar-Wikström; Jakob D Wikström
Journal:  Acta Derm Venereol       Date:  2021-04-15       Impact factor: 3.875

Review 8.  Role of ceramide in diabetes mellitus: evidence and mechanisms.

Authors:  Sehamuddin Galadari; Anees Rahman; Siraj Pallichankandy; Alaa Galadari; Faisal Thayyullathil
Journal:  Lipids Health Dis       Date:  2013-07-08       Impact factor: 3.876

Review 9.  TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists.

Authors:  M V Blagosklonny
Journal:  Cell Death Dis       Date:  2013-12-12       Impact factor: 8.469

Review 10.  Diabetes and beta cell function: from mechanisms to evaluation and clinical implications.

Authors:  Simona Cernea; Minodora Dobreanu
Journal:  Biochem Med (Zagreb)       Date:  2013       Impact factor: 2.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.